why choose us

Clinical Trials Search

Showing 13,720 of 132,366 result(s)
Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink

Status: COMPLETED

Condition: Binge Drinking

Interventions: After an 8-hour overnight fast, the participants ingested ?-nicotinamide Mononucleotide capsules with a single morning dose of 1000mg.
The purity

Date: 2023-03-16

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma in Patients Undergoing Craniotomy

Status: Completed

Condition: Recurrent Glioblastoma

Interventions: Receive IT

Date: 2023-03-16

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

Status: Completed

Condition: Type 1 Diabetes

Interventions: Allogeneic human stem cell-derived islets.

Date: 2023-03-16

A Study of NST-6179 in Adult Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

Status: Completed

Condition: Intestinal Failure Associated Liver Disease

Interventions: Once daily (QD) oral administration of 800mg (32 mL solution) of NST-6179 for 4 weeks

Date: 2023-03-16

Expressive Writing for Caregivers of Persons With Cancer

Status: Completed

Condition: Quality of Life

Interventions: 4 videoconference-delivered group-based expressive writing sessions

Date: 2023-03-16

Intra-procedural ECG Changes During TAVR

Status: Completed

Condition: Transcatheter Aortic Valve Replacement

Interventions: Intra-procedural ECG changes during TAVR

Date: 2023-03-16

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A;B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and;or Influenza B (Flu B)

Status: NOT_YET_RECRUITING

Condition: SARS-CoV-2

Interventions: The LumiraDx SARS-CoV-2 & Flu A;B test is an automated rapid microfluidic immunofluorescence assay for use with the LumiraDx Platform, for ne

Date: 2023-03-16

The Efficacy and Safety of SerpinPC in Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Status: Completed

Condition: Hemophilia A

Interventions: Administered as SC injection.

Date: 2023-03-16

The Ailliance Post-Market Clinical Study

Status: Completed

Condition: Spinal Deformity

Interventions: Follow-up assessments will be required (therefore interventional) from pre-operative baseline to index surgery for those receiving eligible Medtronic

Date: 2023-03-16

Validation orthèse Pour Gonarthrose

Status: Completed

Condition: Gonarthrosis

Interventions: The participants will wear a Odra knee brace held in place with by a cable fastening system and 3d printed straps for 2 weeks.

Date: 2023-03-16